Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02547922
What this trial is testing

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 147
Not applicableUnknownNCT04058951
What this trial is testing

Plant Versus Animal Dietary Protein and the Effect on Proteinuria

Who this might be right for
Kidney InsufficiencyDiabetes MellitusDiabetes Mellitus, Type 2+6 more
Jens Rikardt Andersen 20
Not applicableLooking for participantsNCT06162546
What this trial is testing

ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank

Who this might be right for
Focal Segmental GlomerulosclerosisProteinuriaNephrotic Syndrome+1 more
Christoph Aufricht 100
Not applicableLooking for participantsNCT06242327
What this trial is testing

An Outcome Analysis of Primary Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 500
Early research (Phase 1)Study completedNCT05562362
What this trial is testing

Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension

Who this might be right for
Healthy Subjects
Travere Therapeutics, Inc. 47
Large-scale testing (Phase 3)Study completedNCT04541043
What this trial is testing

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 119
Not applicableStudy completedNCT01113385
What this trial is testing

Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome

Who this might be right for
Focal Segmental GlomerulosclerosisSteroid Resistant Nephrotic Syndrome
Children's National Research Institute 7
Post-approval studies (Phase 4)Ended earlyNCT01316133
What this trial is testing

Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Astellas Pharma Korea, Inc. 37
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Study completedNCT02550652
What this trial is testing

Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 126
Testing effectiveness (Phase 2)Looking for participantsNCT07582133
What this trial is testing

A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 380
Post-approval studies (Phase 4)Study completedNCT06680349
What this trial is testing

Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis

Who this might be right for
Fibrillary Glomerulonephritis
University of Turin, Italy 21
Large-scale testing (Phase 3)Looking for participantsNCT06711887
What this trial is testing

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 348
Early research (Phase 1)Study completedNCT05955872
What this trial is testing

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 21
Not applicableActive Not RecruitingNCT07754019
What this trial is testing

Serum and Urinary sCD163 in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Bezmialem Vakif University 87
Testing effectiveness (Phase 2)UnknownNCT00569101
What this trial is testing

A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Seoul National University Hospital 9
Not applicableStudy completedNCT00983034
What this trial is testing

The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy

Who this might be right for
Nephrotic SyndromeGlomerulonephritisMembranous Nephropathy
Istanbul University 70
Not applicableStudy completedNCT00298506
What this trial is testing

Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 120
Not applicableStudy completedNCT00255398
What this trial is testing

Kidney Disease Biomarkers

Who this might be right for
Kidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06607016
What this trial is testing

A Clinical Trial With KJ103 in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane Disease
Shanghai Bao Pharmaceuticals Co., Ltd. 12
Next Page